Christopher Lee is currently a PhD Candidate in the joint Harvard-MIT Division of Health Sciences and Technology working in the Koch Institute for Integrative Cancer Research developing new drug delivery techniques and therapeutics for urological diseases. Chris is also a former Director for MIT Hacking Medicine, an organization focused on energizing the healthcare ecosystem through design thinking education and launching healthcare startups. This organization to date has helped facilitate the inception of over 15 companies that has raised $100M+ in financing. In 2016, MIT Hacking Medicine was awarded a Stanford MedX Award in the Education in Health category. Additionally, Chris is also a founder of Recon Therapeutics, a medical device start-up focused on providing an improved platform to help patients mix, dose, and inject therapeutics that are delivered in a powered form. Among his various awards, Chris is a 2015 Forbes 30 Under 30 Honoree, a World Economic Forum Global Shaper, and a former MassChallenge winner.